Barclays PLC 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-14 9:25 pm Purchase | 2026-03-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | Barclays PLC | 763,579 5.960% | 763,579 (New Position) | Filing |